NHS Expands AI X-Ray Tools to Speed Up Lung Cancer Diagnosis in England

Artificial intelligence is being used to help radiologists identify possible lung cancer cases faster across England, as the NHS prepares to roll out AI-powered X-ray tools to every trust by 2029.

The technology is already being used in Surrey and is part of a wider £20 million government investment to improve cancer diagnosis. The tools act as a virtual second pair of eyes for radiologists, helping hospitals prioritise urgent scans and support clinical decision-making.

The rollout comes as lung cancer remains England’s biggest cancer killer. Chest X-rays are one of the most important tools for detecting the disease, with more than 7 million carried out across the NHS every year. By helping radiologists identify the most serious cases earlier, officials hope AI can reduce delays and support faster treatment.

Mike Jones, AI and digital manager at the Royal Surrey NHS Foundation Trust, said speed is critical in lung cancer care.

“Time is really important, the quicker you pick up these subtle cancers the better the prognosis for the patient,” Jones said. He added that AI can help manage the pressure created by the large number of scans hospitals process every day.

AI Is Helping Hospitals Prioritise Critical Scans

One of the biggest changes introduced by the AI system is prioritisation.

Previously, chest X-rays were often reviewed in chronological order. That meant scans were generally assessed based on when they arrived, rather than how urgent they appeared. With AI, scans can be pre-read and flagged if the system detects signs that may need faster review.

This allows patients with potentially serious findings to move higher in the reporting queue. For conditions such as lung cancer, that can make a meaningful difference because earlier detection is closely linked to better outcomes.

Jones said the volume of imaging makes AI support valuable.

“There’s no way a human can look at 800 X-rays every day to tell you which ones are the most critical,” he said. “To have the AI there filling in those gaps is what you can’t replace.”

The system does not replace radiologists. Instead, it helps them manage workload and focus attention where it may be needed most urgently.

A Second Pair of Eyes for Radiologists

The AI tools also provide clinical decision support.

After reading a scan, the system highlights findings for hospital staff. Radiologists can then review the AI’s assessment, compare it with their own interpretation, and decide how to report the case.

Jones described this as giving patients “the best of both worlds.” They get an AI read, but the human clinician still has full control over the final report. If the radiologist disagrees with the AI, they can override it. If the AI and human findings both add value, the clinician can combine them into the final assessment.

This model is important because medical AI remains a support tool, not an independent diagnostic authority. In healthcare, accuracy, accountability, and clinical judgement are essential. AI can help identify patterns, but doctors and radiologists remain responsible for decisions.

The approach also addresses one of the common concerns about AI in medicine: whether machines will replace healthcare staff. Officials involved in the rollout are stressing that the technology is meant to supplement clinicians, not remove them from the process.

Faster Reporting Could Help Patients Start Treatment Sooner

The government says the technology is already helping more than 4 million people receive a faster diagnosis or an all-clear for lung cancer.

Early data suggests AI-assisted tools are helping radiologists analyse scans in an average of four days, compared with eight days for the most complex cases previously. Cutting that time matters because cancer care depends heavily on early diagnosis and fast movement through the treatment pathway.

The tools are expected to help more patients begin treatment within 62 days of a GP referral, which is the standard used for cancer waiting times.

Delays in cancer diagnosis can have serious consequences. Patients may wait longer for confirmation, treatment planning, surgery, chemotherapy, radiotherapy, or specialist care. If AI can reduce the time between scan and report, it may help hospitals move patients through the system more efficiently.

Jones said earlier detection could lead to more people surviving lung cancer because the disease can be picked up sooner.

Government Says AI Supports, Not Replaces, Clinicians

Ian Murray, the minister for digital data and modernising government, said AI should be seen as a tool that supports human expertise.

He said AI “isn’t replacing the clinicians, it’s not replacing the human, it’s actually supplementing that.”

Murray also pointed to other examples of AI helping in urgent care, including stroke diagnosis. He said a patient could be diagnosed as having a stroke within three minutes instead of 60 minutes, and that the time saved could make a major difference to survival, recovery, and treatment.

His comments reflect a wider government push to use AI in the NHS where it can reduce delays, improve decision-making, and support pressured clinical teams.

In lung cancer diagnosis, the value comes from combining machine speed with human judgement. Murray said there may be cases where AI detects something the human eye misses, and other cases where a clinician detects something AI does not. Bringing both together can create a stronger result.

Adoption Across NHS Trusts Will Be Key

AI-powered X-ray tools are currently available in about half of NHS trusts in England. The government says they will be rolled out to all trusts by 2029.

That rollout will not depend only on the technology itself. Hospitals will need staff training, workflow changes, data systems, clinical governance, procurement support, and trust from radiologists and patients.

Preet Kaur Gill, Parliamentary Under Secretary of State in the Department of Health and Social Care, said adoption will be critical. She said NHS trusts need support to help staff use the technology effectively.

That point matters because AI tools can fail to deliver value if they are added to hospitals without being properly integrated. For radiology teams, the system must fit into existing reporting workflows, alert processes, patient pathways, and clinical accountability structures.

The technology may be powerful, but its impact will depend on whether hospitals can use it consistently and safely.

AI Could Ease Pressure on Radiology Services

Radiology is one of the most pressured areas of modern healthcare. Demand for imaging continues to grow, while hospitals face workforce constraints and rising diagnostic backlogs.

AI cannot solve all of those problems, but it can help reduce some of the pressure by sorting scans, flagging urgent cases, and giving clinicians extra support during review.

For lung cancer, the potential benefit is especially clear. Many early cancers are subtle and can be difficult to spot. If AI can help highlight suspicious findings, it may reduce the chance that early signs are missed or delayed in busy reporting systems.

At the same time, AI tools must be monitored carefully. False positives can create unnecessary anxiety and extra work. False negatives can create dangerous reassurance. Hospitals will need to track performance, review errors, and ensure that the tools improve care rather than simply adding another layer to the system.

A Step Toward AI-Assisted Cancer Care

The NHS rollout shows how artificial intelligence is moving from experimental healthcare pilots into wider clinical use.

Lung cancer diagnosis is a practical place for AI to make an impact because the NHS already processes millions of chest X-rays each year, and faster reporting can directly affect patient pathways. The technology does not need to replace radiologists to be useful. It needs to help them spot urgent cases sooner, manage workload better, and reduce delays.

The government’s plan to expand the tools to all NHS trusts by 2029 suggests AI will become a normal part of diagnostic medicine in England over the next few years.

The challenge now is execution. Hospitals must adopt the tools safely, clinicians must trust them enough to use them properly, and patients must see real benefits in faster diagnosis and treatment.

If the rollout works, AI could become an important support system in lung cancer care. It will not replace the human expertise behind diagnosis, but it may help clinicians find the cases that need urgent attention before time is lost.